Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Vtv Theraptcs Cl A (VTVT)

Vtv Theraptcs Cl A (VTVT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 161,302
  • Shares Outstanding, K 67,774
  • Annual Sales, $ 2,760 K
  • Annual Income, $ -13,040 K
  • 60-Month Beta -1.81
  • Price/Sales 57.62
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.10
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.16
  • Prior Year -0.10
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.11 +18.01%
on 07/08/20
3.31 -24.77%
on 07/29/20
+0.22 (+9.69%)
since 07/02/20
3-Month
2.01 +23.88%
on 05/07/20
3.31 -24.77%
on 07/29/20
+0.42 (+20.29%)
since 05/04/20
52-Week
1.23 +102.44%
on 08/07/19
4.23 -41.13%
on 02/10/20
+1.19 (+91.54%)
since 08/02/19

Most Recent Stories

More News
vTv Therapeutics Announces 2020 Second Quarter Financial Results and Update

vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the second quarter ended June 30, 2020, and provided an update on the progress of its clinical programs.

VTVT : 2.49 (+4.62%)
vTv Therapeutics to Present Additional Clinical Data from the STEADFAST Study of Azeliragon at the Virtual Alzheimer's Association International Conference

vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that the Company will present at the upcoming 2020 Alzheimer's Association International Conference (AAIC), held virtually, July 27-31, 2020.

VTVT : 2.49 (+4.62%)
Thinking about buying stock in vTv Therapeutics, Norwegian Cruise Line, IZEA Worldwide, Spirit Airlines, or Nokia?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VTVT, NCLH, IZEA, SAVE, and NOK.

NOK : 5.10 (+0.79%)
NCLH : 13.56 (+3.83%)
SAVE : 16.50 (+7.35%)
VTVT : 2.49 (+4.62%)
vTv Therapeutics Presents Two Late-Breaking Poster Sessions on Simplici-T1 Study at the American Diabetes Association's Virtual Sessions Supporting the Potential of TTP399 as First-in-Class Oral Adjunctive Therapy for Type 1 Diabetes Patients

- Treatment with TTP399 resulted in significant improvements in HbA1c with reduction in insulin, without increasing risk of hypoglycemia or diabetic ketoacidosis (DKA) -

VTVT : 2.49 (+4.62%)
vTv Therapeutics to Present Full Clinical Study Results from the Positive Phase 2 Simplici-T1 Study of TTP399, Potential First-in-Class Oral Adjunctive Therapy for Patients with Type 1 Diabetes at the American Diabetes Association's 80th Virtual Scientific Sessions

vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that two late-breaking abstracts reinforcing the potential of TTP399 as an oral adjunctive therapy in type 1 diabetes will be presented virtually at...

VTVT : 2.49 (+4.62%)
vTv Therapeutics Changes its 2020 Annual Meeting of Stockholders to Virtual Format

vTv Therapeutics Inc. (Nasdaq:VTVT) today announced that it will host its 2020 Annual Meeting of Stockholders (the "Annual Meeting") as a virtual-only meeting that will be held via live audio webcast due...

VTVT : 2.49 (+4.62%)
vTv Therapeutics Announces 2020 First Quarter Financial Results and Update

vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the first quarter ended March 31, 2020, and provided an update on recent clinical achievements.

VTVT : 2.49 (+4.62%)
Has vTv Therapeutics (VTVT) Outpaced Other Medical Stocks This Year?

Is (VTVT) Outperforming Other Medical Stocks This Year?

VTVT : 2.49 (+4.62%)
vTv Therapeutics Inc. (VTVT) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in vTv Therapeutics Inc. (VTVT).

VTVT : 2.49 (+4.62%)
vTv Therapeutics Announces 2019 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the fourth quarter and year ended December 31, 2019, and provided an update on recent clinical achievements.

VTVT : 2.49 (+4.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade VTVT with:

Business Summary

vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the discovery and development of orally administered small molecule drug candidates to fill unmet medical needs. Its drug candidate for the treatment of Alzheimers disease includes azeliragon TTP488, which is in Phase III clinical...

See More

Key Turning Points

2nd Resistance Point 2.55
1st Resistance Point 2.46
Last Price 2.49
1st Support Level 2.30
2nd Support Level 2.23

See More

52-Week High 4.23
Fibonacci 61.8% 3.08
Fibonacci 50% 2.73
Last Price 2.49
Fibonacci 38.2% 2.38
52-Week Low 1.23

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar